5 Best S&P 500 Stocks To Buy According to Analysts

4. Insulet Corporation (NASDAQ:PODD)

Number of Q4 2023 Hedge Fund Shareholders: 50

Average Analyst Share Price Target: $237

Percentage Upside: 38.20%

Insulet Corporation (NASDAQ:PODD) is a specialty medical devices company that makes and sells products that help diabetics take insulin. It’s one of the highest rated stocks on our list, with an average share rating of Strong Buy. The average share price target of $237 also prices in a nice 38.20% upside.

As of December 2023 end, 50 out of the 933 hedge funds profiled by Insider Monkey were the firm’s shareholders. The biggest Insulet Corporation (NASDAQ:PODD) shareholder in our database is Ken Griffin’s Citadel Investment Group as it owns 1.3 million shares that are worth $288 million.

Follow Insulet Corp (NASDAQ:PODD)